hotspot -WSS

hotspot

author：hotspot 2025-09-30 00:02:00 - browse：2

Vertex Pharmaceuticals Inc. building — Craig F. Walker/The Boston Globe

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.

The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients. In 2021, Vertex announced dramatic results from the first man to receive the treatment, but researchers cautioned it was just one person, who had only been followed for 90 days.

“The data look as good as they could be,” said Jeanne Loring, a stem cell expert and professor emeritus at Scripps Research not involved in the work, in an email.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Readout LOUD podcast: Venture capital turmoil, obesity drug competition

WSS

The drug industry has found itself all alone in Washington

First medicine developed to treat MASH expected to be approved soon

The drug industry has found itself all alone in Washington

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Former medical device CEO who sold dummy, plastic parts convicted of fraud

entertainment

hotspot

leisure time

DIEP, the 'gold standard' of breast reconstruction, is under threat

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

The cancer drug shortage isn’t new — and neither are the solutions

RSV shot was 90% effective at preventing hospitalizations in kids

The cancer drug shortage isn’t new — and neither are the solutions

Change Healthcare payments predicted restored March 15

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What it’s like to watch children die of measles

hotspot

CDC marks new Covid

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

UnitedHealth quietly bought dozens of outpatient centers

entertainment

focus

entertainment

explore